Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis. Liu Y, Liu F, Wang C, Yan Y, et al. Oncologist 2025;30:oyaf266.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Y, Liu F, Wang C, Yan Y, et al. Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis. Oncologist 2025;30:oyaf266.
PMID: 40854149